ArticleBreast cancer research : BCR2012

A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.

Xuejun Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.